Upamostat (WX-671, Mesupron) is a drug which acts as an inhibitor of the serine protease enzyme urokinase.

It is under development as a potential treatment agent for pancreatic cancer, acting to inhibit tumour metastasis.

[1][2][3]

This antineoplastic or immunomodulatory drug article is a stub.

You can help Wikipedia by expanding it.